News & Views | Published:

Predicting leukemia relapse

Nature Medicine volume 24, pages 385387 (2018) | Download Citation

Mass cytometry of acute B cell lymphoblastic leukemias at diagnosis reveals intrapatient phenotypic heterogeneity and specific signatures that mimic cell developmental stage and predict future relapse.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Science 194, 23–28 (1976).

  2. 2.

    & Nat. Med. 23, 1135–1145 (2017).

  3. 3.

    & N. Engl. J. Med. 373, 1541–1552 (2015).

  4. 4.

    & Lancet Oncol. 14, e205–e217 (2013).

  5. 5.

    et al. Nat. Commun. 6, 6604 (2015).

  6. 6.

    et al. Nat. Med. 24, 474–483 (2018).

  7. 7.

    & Cell 165, 780–791 (2016).

  8. 8.

    Clin. Lab. Med. 37, 945–964 (2017).

  9. 9.

    , , & Blood 126, 144–152 (2015).

  10. 10.

    , & Trends Genet. 33, 155–168 (2017).

  11. 11.

    et al. Nat. Methods 13, 269–275 (2016).

Download references

Author information

Affiliations

  1. José Ignacio Martín-Subero is at Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain and the Department of Basic Clinical Practice, University of Barcelona, Barcelona, Spain.

    • José Ignacio Martín-Subero

Authors

  1. Search for José Ignacio Martín-Subero in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to José Ignacio Martín-Subero.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm.4529

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing